POULTON STUART (EVP, Chief Development Officer) sold 0.2% of their position (189.00 shares) of KARYOPHARM THERAPEUTICS INC. on the open market
Open‑market sale worth $1.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/30/2026ACC: 0001193125-26-326290
Officer· EVP, Chief Development Officer
Since Mar 2026
-189.00
Net shares
Net seller
$1.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
189.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−189.00
Price / share
$7.10
Trade value
$1.34K
% of position
0.2%
7/28/2026
94.82K→94.63K
Total
Net shares
−189.00
Net value
-$1.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/28/2026 | S · Sale | −189.00 | $7.10 | $1.34K | 0.2% | 94.82K | 94.63K |
| Total | −189.00 | -$1.34K | ||||||
Derivative Transactions0
No derivative transactions reported